SODIUM CHLORIDE NORMAL SALT- sodium chloride tablet 
Citragen Pharmaceuticals Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Sodium Chloride Tablets, USP

Drug Facts

Active ingredient (in each tablet)

Sodium Chloride, USP 500 mg

Purpose

Electrolyte Replenisher

Uses

Warnings

Do not use without consulting a physician

Ask a physician before use if you have a sodium restricted diet due to multiple organ diseases

Stop use and ask a physician if symptoms of heat cramps continue for more than 24 hours.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other Information:

Questions or comments?

Phone: +1-510-249-9066 (9AM-5PM PST, Mon-Fri); e-mail: info@citragenpharma.com

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Manufactured by:

CitraGen Pharmaceuticals, Inc.,
Fremont, CA 94538.

www.citragenpharma.com

Rev. 07/20 R-00

CitraGen Pharmaceuticals, Inc.

NDC: 70369‐010‐09

Sodium Chloride Tablets, USP 500 mg

Normal salt tablets

For solution or oral use

200 tablets

200 Count Bottle Label

SODIUM CHLORIDE  NORMAL SALT
sodium chloride tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70369-010
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE500 mg
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize9mm
FlavorImprint Code CG010
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70369-010-09200 in 1 BOTTLE; Type 0: Not a Combination Product07/20/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34907/20/2020
Labeler - Citragen Pharmaceuticals Inc (024949457)
Registrant - Citragen Pharmaceuticals Inc (024949457)
Establishment
NameAddressID/FEIBusiness Operations
Citragen Pharmaceuticals Inc024949457manufacture(70369-010)

Revised: 12/2022
Document Id: f075f533-aec5-1793-e053-2a95a90a786b
Set id: aae783b2-18fe-69ca-e053-2a95a90a0800
Version: 2
Effective Time: 20221222
 
Citragen Pharmaceuticals Inc